Gain Therapeutics (GANX) Earnings Date & Reports

Gain Therapeutics Inc is a biotechnology company developing novel small molecule therapeutics to treat diseases across, several therapeutics areas, including, lysosomal storage disorders, central nervous system disorders, metabolic disorders, and oncology... Show more

Get AI intraday signals

A.I. Advisor

published Earnings

GANX is expected to report earnings to rise 132.50% to -18 cents per share on May 07

Gain Therapeutics GANX Stock Earnings Reports

Q1'25

Est.

$-0.19

Q4'24

Beat

by $0.10

Q3'24

Beat

by $0.04

Q2'24

Missed

by $0.23

Q1'24

Beat

by $0.09

The last earnings report on March 27 showed earnings per share of -7 cents, beating the estimate of -18 cents. With 222.64K shares outstanding, the current market capitalization sits at 43.90M.

View a ticker or compare two or three

Compare

GANX